MoonLake Immunotherapeutics Logo (full size)
MoonLake Immunotherapeutics Logo icon/symbol
MoonLake Immunotherapeutics Logo (full size) on a dark background
MoonLake Immunotherapeutics Logo icon/symbol on a dark background
About MoonLake Immunotherapeutics
MoonLake Immunotherapeutics, a clinical stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseases. It develops Sonelokimab, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody for the treatment of inflammatory diseases, as well as for hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, palmoplantar pustulosis, and psoriasis. The company was founded in 2021 and is headquartered in Zug, Switzerland.
July 6th, 2024
